New clinical trials are examining tirzepatide and semaglutide.
Many don't realize that after drug/alcohol treatment, San Francisco does not have a permanent place for people to go if they want to continue being sober.
The City of San Francisco recently told nonprofits that if they wanted to continue distributing things like Narcan or smoking kits, they must also offer counseling and information on treatment. Those that don't comply will lose city funding.
With overdose deaths continuing to rise, a shift is unfolding in San Francisco: one that pits harm reduction orthodoxy against a growing call for sobriety-based supportive housing.
Supervisor Matt Dorsey's proposed shift in San Francisco's drug policy heads to committee Thursday as the city's overdose deaths have been climbing back up after a promising drop last year.
New research data shows a new, oral GLP-1 medication can potentially benefit people with Type 2 diabetes.